Seasonal influenza in children: Costs for the health system and society in Europe

L Villani, F D'Ambrosio, R Ricciardi… - Influenza and Other …, 2022 - Wiley Online Library
Background Pediatric influenza causes significant morbidity annually, resulting in an
increased economic burden. Therefore, we aimed to summarize existing literature regarding …

Available evidence and potential for vaccines for reduction in antibiotic prescriptions

G Gabutti - Human Vaccines & Immunotherapeutics, 2022 - Taylor & Francis
Bacterial antibiotic resistance is a public health issue. It means that drugs become
ineffective, infections persist and have a huge impact on the health of patients and their …

Predictors of seasonal influenza vaccination willingness among high-risk populations three years after the onset of the COVID-19 pandemic

A Katsiroumpa, P Sourtzi, D Kaitelidou, O Siskou… - Vaccines, 2023 - mdpi.com
High-risk populations are at increased risk of severe influenza-related illness,
hospitalization, and death due to influenza. The aim of our study was to assess the …

The new quadrivalent adjuvanted influenza vaccine for the Italian elderly: a health technology assessment

GE Calabrò, S Boccalini, D Panatto, C Rizzo… - International Journal of …, 2022 - mdpi.com
Background. The elderly, commonly defined as subjects aged≥ 65 years, are among the at-
risk subjects recommended for annual influenza vaccination in European countries …

Detection of influenza virus in urban wastewater during the season 2022/2023 in Sicily, Italy

CM Maida, W Mazzucco, W Priano, R Palermo… - Frontiers in Public …, 2024 - frontiersin.org
Introduction Seasonal influenza generally represents an underestimated public health
problem with significant socioeconomic implications. Monitoring and detecting influenza …

Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population

S Marbaix, N Dauby, J Mould-Quevedo - Expert review of vaccines, 2023 - Taylor & Francis
ABSTRACT Background Between 2015 and 2019, when 62% of Belgian adults aged≥ 65
years were vaccinated with standard quadrivalent influenza vaccines, influenza caused an …

Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in …

SI Pelton, JF Mould-Quevedo… - Expert Review of …, 2024 - Taylor & Francis
Background Cell-based quadrivalent influenza vaccines (QIVc) can increase effectiveness
against seasonal influenza by avoiding mismatch from egg adaption of vaccine viruses. This …

Nanovaccines to combat drug resistance: the next-generation immunisation

K Manju, SN Raj, HK Ranjini, SC Nayaka… - Future Journal of …, 2023 - Springer
Background The present review envisages the role of nanovaccines to combat the global
challenges of antimicrobial resistance. Nanovaccines are a novel formulation comprised of …

Antiviral peptides as anti-influenza agents

M Agamennone, M Fantacuzzi, G Vivenzio… - International Journal of …, 2022 - mdpi.com
Influenza viruses represent a leading cause of high morbidity and mortality worldwide.
Approaches for fighting flu are seasonal vaccines and some antiviral drugs. The …

Adjuvanted versus non-adjuvanted standard-dose influenza vaccines in preventing all-cause hospitalizations in the elderly: a cohort study with nested case-control …

F Lapi, A Domnich, E Marconi, A Rossi… - Expert Review of …, 2022 - Taylor & Francis
Background The higher effectiveness of adjuvanted trivalent influenza vaccine (aTIV) versus
non-adjuvanted (na) formulations in preventing all-cause hospitalization has been …